141 related articles for article (PubMed ID: 36423900)
21. Fentanyl Concentration in Drug Checking Samples and Risk of Overdose Death in Vancouver, Canada.
Kennedy MC; Dong H; Tobias S; Buxton JA; Lysyshyn M; Tupper KW; Ti L
Am J Prev Med; 2024 Jan; 66(1):10-17. PubMed ID: 37633426
[TBL] [Abstract][Full Text] [Related]
22. Drug checking services at music festivals and events in a Canadian setting.
McCrae K; Tobias S; Tupper K; Arredondo J; Henry B; Mema S; Wood E; Ti L
Drug Alcohol Depend; 2019 Dec; 205():107589. PubMed ID: 31605958
[TBL] [Abstract][Full Text] [Related]
23. Beyond a spec: assessing heterogeneity in the unregulated opioid supply.
Gozdzialski L; Louw R; Kielty C; Margolese A; Poarch E; Sherman M; Cameron F; Gill C; Wallace B; Hore D
Harm Reduct J; 2024 Mar; 21(1):63. PubMed ID: 38491435
[TBL] [Abstract][Full Text] [Related]
24. A survey of North American drug checking services operating in 2022.
Park JN; Tardif J; Thompson E; Rosen JG; Lira JAS; Green TC
Int J Drug Policy; 2023 Nov; 121():104206. PubMed ID: 37797571
[TBL] [Abstract][Full Text] [Related]
25. Fatalities Involving Carfentanil and Furanyl Fentanyl: Two Case Reports.
Swanson DM; Hair LS; Strauch Rivers SR; Smyth BC; Brogan SC; Ventoso AD; Vaccaro SL; Pearson JM
J Anal Toxicol; 2017 Jul; 41(6):498-502. PubMed ID: 28575422
[TBL] [Abstract][Full Text] [Related]
26. Rapid and accurate etizolam detection using surface-enhanced Raman spectroscopy for community drug checking.
Gozdzialski L; Rowley A; Borden SA; Saatchi A; Gill CG; Wallace B; Hore DK
Int J Drug Policy; 2022 Apr; 102():103611. PubMed ID: 35151084
[TBL] [Abstract][Full Text] [Related]
27. Xylazine detected in unregulated opioids and drug administration equipment in Toronto, Canada: clinical and social implications.
Bowles JM; McDonald K; Maghsoudi N; Thompson H; Stefan C; Beriault DR; Delaney S; Wong E; Werb D
Harm Reduct J; 2021 Oct; 18(1):104. PubMed ID: 34645480
[TBL] [Abstract][Full Text] [Related]
28. Effect of witnessing an overdose on the use of drug checking services among people who use illicit drugs in Vancouver, Canada.
Beaulieu T; Hayashi K; Nosova E; Milloy MJ; DeBeck K; Wood E; Kerr T; Ti L
Am J Drug Alcohol Abuse; 2020 Jul; 46(4):506-511. PubMed ID: 31983241
[TBL] [Abstract][Full Text] [Related]
29. Validation of a lateral flow chromatographic immunoassay for the detection of fentanyl in drug samples.
Park JN; Sherman SG; Sigmund V; Breaud A; Martin K; Clarke WA
Drug Alcohol Depend; 2022 Nov; 240():109610. PubMed ID: 36115223
[TBL] [Abstract][Full Text] [Related]
30. Drug checking at an electronic dance music festival during the public health overdose emergency in British Columbia.
Mema SC; Sage C; Xu Y; Tupper KW; Ziemianowicz D; McCrae K; Leigh M; Munn MB; Taylor D; Corneil T
Can J Public Health; 2018 Dec; 109(5-6):740-744. PubMed ID: 30251119
[TBL] [Abstract][Full Text] [Related]
31. Point-of-care community drug checking technologies: an insider look at the scientific principles and practical considerations.
Gozdzialski L; Wallace B; Hore D
Harm Reduct J; 2023 Mar; 20(1):39. PubMed ID: 36966319
[TBL] [Abstract][Full Text] [Related]
32. Detection of fentanyl and fentanyl analogues in biological samples using liquid chromatography-high resolution mass spectrometry.
Rab E; Flanagan RJ; Hudson S
Forensic Sci Int; 2019 Jul; 300():13-18. PubMed ID: 31063883
[TBL] [Abstract][Full Text] [Related]
33. An assessment of the limits of detection, sensitivity and specificity of three devices for public health-based drug checking of fentanyl in street-acquired samples.
Green TC; Park JN; Gilbert M; McKenzie M; Struth E; Lucas R; Clarke W; Sherman SG
Int J Drug Policy; 2020 Mar; 77():102661. PubMed ID: 31951925
[TBL] [Abstract][Full Text] [Related]
34. Enhancing drug checking services for supply monitoring: perspectives on implementation in syringe service programs in the USA.
Moon KJ; Whitehead HD; Trinh A; Hasenstab KA; Hayes KL; Stanley D; Carter B; Barclay R; Lieberman M; Nawaz S
Harm Reduct J; 2024 Jan; 21(1):11. PubMed ID: 38218980
[TBL] [Abstract][Full Text] [Related]
35. Current attitudes toward drug checking services and a comparison of expected with actual drugs present in street drug samples collected from opioid users.
Swartz JA; Lieberman M; Jimenez AD; Mackesy-Amiti ME; Whitehead HD; Hayes KL; Taylor L; Prete E
Harm Reduct J; 2023 Jul; 20(1):87. PubMed ID: 37420196
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive testing and rapid dissemination of local drug supply surveillance data in Rhode Island.
Collins AB; Wightman RS; Macon EC; Guan Y; Shihipar A; Krieger M; Elmaleh R; Smith MC; Morales A; Badea A
Int J Drug Policy; 2023 Aug; 118():104118. PubMed ID: 37422985
[TBL] [Abstract][Full Text] [Related]
37. Recommendations from people who use drugs in Philadelphia, PA about structuring point-of-care drug checking.
Reed MK; Borne E; Esteves Camacho T; Kelly M; Rising KL
Harm Reduct J; 2024 Jan; 21(1):26. PubMed ID: 38287409
[TBL] [Abstract][Full Text] [Related]
38. Fentanyl, heroin, and methamphetamine-based counterfeit pills sold at tourist-oriented pharmacies in Mexico: An ethnographic and drug checking study.
Friedman J; Godvin M; Molina C; Romero R; Borquez A; Avra T; Goodman-Meza D; Strathdee S; Bourgois P; Shover CL
Drug Alcohol Depend; 2023 Aug; 249():110819. PubMed ID: 37348270
[TBL] [Abstract][Full Text] [Related]
39. Is expected substance type associated with timing of drug checking service utilization?: A cross-sectional study.
Beaulieu T; Wood E; Tobias S; Lysyshyn M; Patel P; Matthews J; Ti L
Harm Reduct J; 2021 Jun; 18(1):66. PubMed ID: 34176497
[TBL] [Abstract][Full Text] [Related]
40. Distribution of take-home opioid antagonist kits during a synthetic opioid epidemic in British Columbia, Canada: a modelling study.
Irvine MA; Buxton JA; Otterstatter M; Balshaw R; Gustafson R; Tyndall M; Kendall P; Kerr T; Gilbert M; Coombs D
Lancet Public Health; 2018 May; 3(5):e218-e225. PubMed ID: 29678561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
